Could a diabetes shot shield heart and kidneys? new trial seeks answers
NCT ID NCT02251431
First seen Mar 09, 2026 · Last updated May 22, 2026 · Updated 15 times
Summary
This study tested whether a once-weekly injection of exenatide (a diabetes drug) could improve heart and kidney health in 57 adults with type 2 diabetes, mild kidney disease, and early heart stiffness. Participants received either the drug or a placebo for 38 weeks. Researchers measured blood and urine markers of heart strain and kidney damage, along with MRI and ultrasound scans, to see if exenatide offers extra protection beyond blood sugar control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor Scott and White Research Institute- Baylor Heart and Vascular Hospital
Dallas, Texas, 75226, United States
Conditions
Explore the condition pages connected to this study.